Literature DB >> 6885899

Stimulating effect of ascorbic acid on ascites tumor cell multiplication in vitro.

F S Liotti, M Bodo, V Talesa.   

Abstract

In a preceding report evidence has been presented that ascorbic acid (AA) accelerated solid tumor growth obtained by inoculating tumor ascites cells into the subcutaneous dorsal region of inbred Balb/cf/Had/Se substrain mice. The present work investigates whether this effect is the result of a direct action of AA on neoplastic cell multiplication or of an indirect action on the tumor cells mediated by changes induced by AA in the organism bearing the tumor. The results obtained demonstrate that AA at low doses (microgram 10-30/ml) stimulates ascites tumor cell multiplication in vitro, while at high doses (microgram 60-120/ml) the opposite occurs. These results suggest that the major growth of solid tumors observed in mice treated with AA may be attribute to the capacity of this substance to favor the multiplication of ATP cells which were used to induce the tumors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6885899     DOI: 10.1007/bf00399900

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  3 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  The Gradual Conversion of a Spontaneous Mouse Mammary Carcinoma to an Ascites Tumour.

Authors:  C Biancifiori; F Caschera
Journal:  Br J Cancer       Date:  1960-12       Impact factor: 7.640

Review 3.  Ascorbic acid and cancer: a review.

Authors:  E Cameron; L Pauling; B Leibovitz
Journal:  Cancer Res       Date:  1979-03       Impact factor: 12.701

  3 in total
  1 in total

1.  Effects of ascorbic and dehydroascorbic acid on the multiplication of tumor ascites cells in vitro.

Authors:  F S Liotti; A R Menghini; P Guerrieri; V Talesa; M Bodo
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.